article thumbnail

SAEM Clinical Images Series: A Blistery Mystery

ALiEM - Pharm Pearls

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder caused by autoantibodies against platelet antigens. Case Discussion Take-Home Points Immune thrombocytopenia is an acquired isolated thrombocytopenia that can be a primary disorder or secondary to viral illness, autoimmune syndrome, or immunodeficiency disease.

Immunity 152
article thumbnail

The host immune response in COVID-19 and beyond

pharmaphorum

MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us. This is made possible using ‘Advanced Host Immune Response Technologies’.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Health Innovators: PureTech Health’s Daphne Zohar

pharmaphorum

They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020.

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

The vaccination of patients with AN1792 led to the activation of their immune systems, which started producing endogenous anti-Abeta antibodies. Therefore, active immunotherapy to trigger the immune system to produce sustained levels of endogenous antibodies has now become far more attractive.

article thumbnail

How global healthcare partners and Indian pharma companies are contributing to affordable medicines

Express Pharma

Indian pharmaceutical companies play a crucial role in fulfilling global demand for critical vaccines, including those endorsed by the World Health Organization (WHO) for diseases (like Tetanus, Pertussis, Diphtheria, and Bacillus Calmette-Guerin), highlighting India’s indispensable contribution to global immunization efforts.

Vaccines 105
article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

article thumbnail

Merck Reports the US FDA Acceptance of sBLA for Keytruda (pembrolizumab) to Treat Advanced or Unresectable Biliary Tract Cancer

PharmaShots

OS rate (52% & 24.9%